Mumbai, Jan 1: Venus Remedies has been accredited with the European GMP certification, a rare and most coveted certification for regulated markets, for its Cephalosporin and Carbapenem plants at Baddi in northern India.
The Cephalosporin and Carbapenem plants of the Company were inspected by the European authorities, and found to be complying with the manufacturing and quality control standards as per the European goods manufacturing practice, the Company informed.The European GMP certification is a pre-requisite for export to the European Union. With this accreditation, the Company can now freely export to not only 36 countries of the European Union, but also to Canada and Australia, which recognize European GMP.
Now the Company can surge ahead in the regulated European and Canadian markets, as per its strategy, in sync with its subsidiary Venus Pharma GmbH, Germany and realise its export targets as per the projections. The Company has already entered into product development, manufacturing and marketing agreements with leading multi national companies from Europe for its specialty anti-biotic range in the Cephalosporin and Carbapenem segments. Negotiations are underway for similar agreements with leading players of Canadian market.
Venus is the only Company in India to have an EU-GMP certified plant for Carbapenems, which have huge market potential across the globe. This certification has further fortified the foundation for Company's expansion plans and cleared the path for its international foray in regulated markets in a big way.